Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population

ClinicalTrials.gov ID: NCT00071448

Public ClinicalTrials.gov record NCT00071448. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 10:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in the United States of America (USA). The aim of this trial is to to determine whether insulin aspart can be used effectively and safely in paediatric patients.

Study identification

NCT ID
NCT00071448
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
378 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years to 18 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2002 (Type not available)
Primary completion
Jun 2004 (Actual)
Completion
Jun 2004 (Actual)
Last update posted
Dec 22, 2016

2002 – 2004

United States locations

U.S. sites
76
U.S. states
32
U.S. cities
67
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35294 —
Novo Nordisk Investigational Site Mobile Alabama 36617 —
Novo Nordisk Investigational Site Phoenix Arizona 85013 —
Novo Nordisk Investigational Site Tucson Arizona 85712 —
Novo Nordisk Investigational Site Loma Linda California 92354 —
Novo Nordisk Investigational Site Long Beach California 90806 —
Novo Nordisk Investigational Site Los Angeles California 90027 —
Novo Nordisk Investigational Site Sacramento California 95817 —
Novo Nordisk Investigational Site San Diego California 92093 —
Novo Nordisk Investigational Site San Diego California 92123 —
Novo Nordisk Investigational Site Englewood Colorado 80110 —
Novo Nordisk Investigational Site Hartford Connecticut 06106 —
Novo Nordisk Investigational Site New Haven Connecticut 06520 —
Novo Nordisk Investigational Site Gainesville Florida 32605 —
Novo Nordisk Investigational Site Gainesville Florida 32608 —
Novo Nordisk Investigational Site Miami Florida 33136 —
Novo Nordisk Investigational Site Orlando Florida 32806-1101 —
Novo Nordisk Investigational Site Pensacola Florida 32504 —
Novo Nordisk Investigational Site Tallahassee Florida 32308 —
Novo Nordisk Investigational Site Tampa Florida 33612 —
Novo Nordisk Investigational Site Atlanta Georgia 30342 —
Novo Nordisk Investigational Site Idaho Falls Idaho 83404-7596 —
Novo Nordisk Investigational Site Indianapolis Indiana 46202-2879 —
Novo Nordisk Investigational Site Indianapolis Indiana 46250 —
Novo Nordisk Investigational Site Iowa City Iowa 52242 —
Novo Nordisk Investigational Site Baton Rouge Louisiana 70808 —
Novo Nordisk Investigational Site New Orleans Louisiana 70127-5430 —
Novo Nordisk Investigational Site Baltimore Maryland 21201 —
Novo Nordisk Investigational Site Baltimore Maryland 21229 —
Novo Nordisk Investigational Site Boston Massachusetts 02115 —
Novo Nordisk Investigational Site Boston Massachusetts 02215 —
Novo Nordisk Investigational Site Worcester Massachusetts 01655 —
Novo Nordisk Investigational Site Ann Arbor Michigan 48109 —
Novo Nordisk Investigational Site Minneapolis Minnesota 55416 —
Novo Nordisk Investigational Site Rochester Minnesota 55905 —
Novo Nordisk Investigational Site Kansas City Missouri 64108 —
Novo Nordisk Investigational Site Omaha Nebraska 68114 —
Novo Nordisk Investigational Site Omaha Nebraska 68198-3020 —
Novo Nordisk Investigational Site Hackensack New Jersey 07601 —
Novo Nordisk Investigational Site Morristown New Jersey 07962 —
Novo Nordisk Investigational Site Paterson New Jersey 07503 —
Novo Nordisk Investigational Site Albuquerque New Mexico 87102 —
Novo Nordisk Investigational Site Albany New York 12208 —
Novo Nordisk Investigational Site Brooklyn New York 11219 —
Novo Nordisk Investigational Site Buffalo New York 53226 —
Novo Nordisk Investigational Site Mineola New York 11501 —
Novo Nordisk Investigational Site New York New York 10022 —
Novo Nordisk Investigational Site New York New York 10029 —
Novo Nordisk Investigational Site Rochester New York 14642 —
Novo Nordisk Investigational Site Chapel Hill North Carolina 27599-7220 —
Novo Nordisk Investigational Site Akron Ohio 44308-1062 —
Novo Nordisk Investigational Site Cleveland Ohio 44195 —
Novo Nordisk Investigational Site Columbus Ohio 43231 —
Novo Nordisk Investigational Site Dayton Ohio 45404 —
Novo Nordisk Investigational Site Portland Oregon 97227 —
Novo Nordisk Investigational Site Danville Pennsylvania 17822 —
Novo Nordisk Investigational Site Erie Pennsylvania 16507 —
Novo Nordisk Investigational Site Hershey Pennsylvania 17033 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19104 —
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15213-3417 —
Novo Nordisk Investigational Site Charleston South Carolina 29425 —
Novo Nordisk Investigational Site Columbia South Carolina 29203 —
Novo Nordisk Investigational Site Greer South Carolina 29651 —
Novo Nordisk Investigational Site Memphis Tennessee 38103 —
Novo Nordisk Investigational Site Memphis Tennessee 38119 —
Novo Nordisk Investigational Site Corpus Christi Texas 78411 —
Novo Nordisk Investigational Site Dallas Texas 75235 —
Novo Nordisk Investigational Site Lackland City Texas 78236 —
Novo Nordisk Investigational Site San Antonio Texas 78229 —
Novo Nordisk Investigational Site San Antonio Texas 78284 —
Novo Nordisk Investigational Site Temple Texas 76508 —
Novo Nordisk Investigational Site Salt Lake City Utah 84132 —
Novo Nordisk Investigational Site Norfolk Virginia 23510 —
Novo Nordisk Investigational Site Spokane Washington 99201 —
Novo Nordisk Investigational Site Morgantown West Virginia 26506 —
Novo Nordisk Investigational Site Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00071448, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 22, 2016 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00071448 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →